• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Case Rep . Neurotropism of SARS-CoV-2: COVID-19 Presenting With an Acute Manic Episode

tetano

Editor, Senior Moderator
BMJ Case Rep


. 2020 Jun 14;13(6):e236123.
doi: 10.1136/bcr-2020-236123.
Neurotropism of SARS-CoV-2: COVID-19 Presenting With an Acute Manic Episode


Jamie A Mawhinney[SUP] 1 [/SUP], Catherine Wilcock[SUP] 2 [/SUP], Hasan Haboubi[SUP] 3 [/SUP], Shahbaz Roshanzamir[SUP] 2 [/SUP]



Affiliations

Abstract

A 41-year-old man with no significant medical history presented with acute behavioural disruption on the background of a 1-day history of severe headache and a 10-day history of dry cough and fever. He was sexually disinhibited with pressured speech and grandiose ideas. His behaviour worsened, necessitating heavy sedation and transfer to intensive care for mechanical ventilation despite no respiratory indication. Investigations confirmed that he was positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neuroimaging and a lumbar puncture were normal. Initial screening for SARS-CoV-2 in the cerebrospinal fluid was negative although no validated assay was available. The patient's mental state remained abnormal following stepdown from intensive care. Psychiatric assessment found features consistent with acute mania, and he was detained under the Mental Health Act. This case indicates the need to consider COVID-19 in a wider series of clinical presentations and to develop a validated assay for SARS-CoV-2 in the cerebrospinal fluid.

Keywords: infection (neurology); mood disorders (including depression); pneumonia (infectious disease); psychotic disorders (incl schizophrenia).
 
Back
Top Bottom